OTC · SCPS
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Nov 3, 2026, 1:39 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SCPS
1M range · 8 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
SCPS closed at $0.00 after 8 trading sessions, down 33.33% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 400 |
| Oct 26, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 1.8K |
| Oct 15, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 150.03K |
| Oct 13, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 100 |
| Oct 8, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 385 |
| Oct 7, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 150 |
| Oct 6, 2026 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | 1K |
| Oct 5, 2026 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 269 |
The latest Smart Investors Daily articles mentioning SCPS.
Company
Market Activity
Research & News
SCPS research
Company profile and research snapshot.
SCOPUS BIOPHARMA INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 16, 2021 | Benchmark | Speculative Buy | — |
No generated briefing is available yet.
defenseworld.net · Dec 10, 2025
Institutional and Insider Ownership 18.4% of MorphoSys shares are held by institutional investors. 0.1% of MorphoSys shares are held by insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SCPS.
No results
No recent SID articles mention SCPS.
